U.S. Markets open in 2 hrs 28 mins

GlaxoSmithKline Buys Novartis’s Stake in Joint Venture

Sarah Collins
GlaxoSmithKline Buys Novartis’s Stake in Joint Venture

On March 27, 2018, GlaxoSmithKline (GSK) announced an agreement with Novartis (NVS) to buy Novartis’s stake in their consumer healthcare joint venture. GlaxoSmithKline will pay $13 billion for Novartis’s 36.5% stake.